Envision Healthcare Corporation (EVHC) Given Daily News Sentiment Score of 0.19
News articles about Envision Healthcare Corporation (NYSE:EVHC) have trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Envision Healthcare Corporation earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.799119479363 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the news headlines that may have effected Accern Sentiment’s scoring:
- DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Envision Healthcare Corporation (NYSE:EVHC) To Contact The Firm (finance.yahoo.com)
- DEADLINE UPCOMING: Khang & Khang LLP Announces Securities Class Action Lawsuit against Envision Healthcare Corporation and Encourages Investors with Losses to Contact the Firm (finance.yahoo.com)
- Envision Healthcare Corp : Important Deadline Reminder for Envision Healthcare Corporation Shareholders (4-traders.com)
- Envision details new execs’ pay plans (nashvillepost.com)
Envision Healthcare Corporation (NYSE EVHC) opened at 43.62 on Tuesday. Envision Healthcare Corporation has a 12-month low of $42.91 and a 12-month high of $74.75. The stock’s market capitalization is $5.11 billion. The firm has a 50-day moving average of $51.35 and a 200-day moving average of $57.40.
Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.04. The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. Envision Healthcare Corporation’s revenue was up 156.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.34 earnings per share. Equities research analysts forecast that Envision Healthcare Corporation will post $1.40 earnings per share for the current fiscal year.
Envision Healthcare Corporation declared that its Board of Directors has authorized a share buyback program on Monday, September 18th that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s management believes its stock is undervalued.
Several equities research analysts recently commented on the stock. Cantor Fitzgerald reiterated a “buy” rating and issued a $80.00 price objective on shares of Envision Healthcare Corporation in a research report on Tuesday, July 4th. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 price objective on the stock in a research report on Tuesday, July 4th. Royal Bank Of Canada reiterated a “buy” rating and issued a $72.00 price objective on shares of Envision Healthcare Corporation in a research report on Monday, June 5th. Jefferies Group LLC set a $71.00 price objective on shares of Envision Healthcare Corporation and gave the stock a “buy” rating in a research report on Thursday, August 24th. Finally, Mizuho decreased their price objective on shares of Envision Healthcare Corporation from $70.00 to $60.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $71.56.
COPYRIGHT VIOLATION WARNING: This news story was first published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.watchlistnews.com/envision-healthcare-corporation-evhc-given-daily-news-sentiment-score-of-0-19/1588186.html.
In related news, insider Robert Jon Coward sold 1,500 shares of Envision Healthcare Corporation stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $62.69, for a total value of $94,035.00. Following the transaction, the insider now owns 97,863 shares of the company’s stock, valued at approximately $6,135,031.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.10% of the company’s stock.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.